Coramaze raises €4.5M Series A round
2 September 2015· Hilden, Germany· health, medtech, biotech, b2b, deep_hardware
Proceeds will be used to advance the mitramaze implant design concept into a first-in-human clinical investigational study and a subsequent feasibility trial to support European CE approval.
Investors
LeadElron Electronic Industries
Also participating
High-Tech GründerfondsSeedCapital Dortmund
About Coramaze
Stage
Series A
Headquarters
Hilden, Germany
Founded
2013
Team Size
21–50
Sectors
healthmedtechbiotechb2bdeep_hardware
Source: https://www.finsmes.com/2015/09/coramaze-technologies-raises-e4-5m-in-series-a-financing.html